PPACA Impact and Opportunities Health Care Lawyer & Attorney Epstein Becker Green Law Firm

PPACA Impact and Opportunities Health Care Lawyer & Attorney Epstein Becker Green Law Firm

Info iconThis preview shows pages 1–3. Sign up to view the full content.

View Full Document Right Arrow Icon
PPACA Impact and Opportunities : Health Care Musings Blog Published By delivery system About Resources Contact Archives Posted on September 13, 2010 by CMS Proposes to Withdraw Regulations on Average Manufacturer Price Determination, Multiple Source Drug Definition, and Medicaid Federal Upper Limits by Wendy C. Goldstein , Kathleen A. Peterson , Benjamin S. Martin , and Constance A. Wilkinson On September 3, 2010, the Centers for Medicare & Medicaid Services ("CMS") issued a proposed rule withdrawing regulations governing the determination of "Average Manufacturer Price" ("AMP"), the definition of "Multiple Source Drug," and the application of federal upper reimbursement limits ("FULs") for Multiple Source Drugs (the "Proposed Rule"). This withdrawal would impact the applicable regulations finalized by CMS in 2007 and 2008 but would leave intact other sections of the 2007 regulations, including, for example, the "Best Price" provisions and certain "definitions" (including the definition of "bona fide service fee"). Comments may be submitted to CMS until 5:00 p.m. EDT on October 4, 2010. We recommend that organizations consider commenting on the impact of the withdrawn regulations, as well as on the open items that have not been addressed under the recent "health reform" legislation. Download the full alert (PDF) Read the full alert online Tags: Cost of Health Care Email This Print
Background image of page 1

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
Share Link Posted on June 14, 2010 by PPACA Amends Rehabilitation Act to Mandate Standards for Medical Diagnostic Equipment to Accommodate Individuals with Disabilities by Shawn Gilman and Frank C. Morris, Jr. A little-noticed provision of the Patient Protection and Affordable Care Act (PPACA) will significantly impact both health care manufacturers and providers. The provision amends the Rehabilitation Act of 1973 to require regulations by March 23, 2012, mandating that all medical diagnostic equipment and health care provider locations be able to accommodate the needs of individuals with disabilities. This requirement would mean a redesign of both diagnostic equipment and locations for patient interactions to assure that individuals with disabilities who could not utilize currently available diagnostic equipment or provider locations will, in the future, have access to the care and services available to individuals without disabilities. They must be able to have access to—and independently be able to enter, use, and exit—the equipment to the maximum extent possible. This is significant because of the often high cost of diagnostic equipment and space requirements at provider locations.
Background image of page 2
Image of page 3
This is the end of the preview. Sign up to access the rest of the document.

This note was uploaded on 01/16/2011 for the course POLS 1101 taught by Professor Cann during the Fall '08 term at University of Georgia Athens.

Page1 / 20

PPACA Impact and Opportunities Health Care Lawyer & Attorney Epstein Becker Green Law Firm

This preview shows document pages 1 - 3. Sign up to view the full document.

View Full Document Right Arrow Icon
Ask a homework question - tutors are online